Valent BioSciences opens new addition at Melnik and Shafer Biorational Research Center

Greg was also central to the planning, design, and construction of this facility

Central Council for Research in Ayurvedic Sciences launches ‘PRAGATI-2024’

IGC Pharma announces patient enrollment at Neurostudies in Phase 2 trial investigating IGC-AD1

Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's

Zydus announces completion of Enrolment for Phase II clinical trial of Usnoflast

ALS is a rare, progressive and fatal neurodegenerative disease, with an average life expectancy of 3 to 5 years from the time of symptom onset

BaseLaunch announces a new partnership with AbbVie

Further strengthens BaseLaunch's global pharma industry partnerships

Merck to showcase advances in the science of cancer with new data presented at ASCO 2024

Phase I data for tuvusertib, lead asset from the company’s unique portfolio of DDR inhibitors

Hester Biosciences posts Q4 FY24 consolidated profit increases to Rs. 4.95 Cr

The company has posted net profit) of Rs.18.88 crores for the Financial Year ended March 31, 2024

Suven Life Sciences posts Q4 FY24 consolidated loss at Rs. 26.54 Cr

The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024

Astec LifeSciences posts Q4FY24 consolidated loss at Rs. 97.39 lakhs

The company has reported total income of Rs. 155.79 crores during the period ended March 31, 2024

RPG Life Sciences posts Q4 FY24 PAT at Rs. 13.24 Cr

The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024